Menu

US State Department Names New Science Envoys

The five high-profile scientists are charged with helping strengthen international cooperation.

Jun 13, 2018
Shawna Williams

U.S. DIPLOMACY CENTERFive new science envoys have been named to one-year terms that begin this month, the US Department of State announced last week (June 8). The new appointees, Charles Bolden Jr., Robert Langer, Michael Osterholm, Rebecca Richards-Kortum, and James Schauer, join continuing envoys Margaret Leinen and Thomas Lovejoy.

“It’s a unique opportunity to be involved with countries around the world on specific topics through official government channels,” Osterholm, who directs the University of Minnesota’s Center for Infectious Disease Research and Policy, tells Science Insider. He explains that he plans to work in low- and middle-income countries to tackle antibiotic overuse and bacterial resistance to the drugs.

See “Science Envoy Resigns from US State Department in Protest

The envoys, all prominent leaders in their fields, span a range of specializations. Bolden is a former astronaut and NASA administrator; Langer is an MIT professor focusing on biotechnology and materials science; Richards-Kortum directs the Rice 360º Institute for Global Health at Rice University; and Schauer directs the Wisconsin State Laboratory of Hygiene at the University of Wisconsin-Madison.

See “Oceans’ Ambassador

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery extends CRISPR Screening Service to primary human T cells
Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the extension of its CRISPR Screening Service to includeex vivoT lymphocytes. The service extension meets the requirements of immunology-based research in drug discovery,enabling new gene targets to be identified in biologically and potentially therapeutically relevant settings.
pIC50: The Advantages of Thinking Logarithmically
pIC50: The Advantages of Thinking Logarithmically
Watch this webinar from Collaborative Drug Discovery to learn about how using pIC50 helps you get a better sense of the relative potencies, calculate the correct mean of multiple values, and select better sampling doses.
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.